These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 19596187)

  • 1. Metalloproteolytic balance in asthma: when and how could its regulation?
    Gardella C; Panigada S; Rossi GA
    Respir Med; 2009 Nov; 103(11):1589-91. PubMed ID: 19596187
    [No Abstract]   [Full Text] [Related]  

  • 2. Budesonide/formoterol effects on metalloproteolytic balance in TGFbeta-activated human lung fibroblasts.
    Todorova L; Gürcan E; Westergren-Thorsson G; Miller-Larsson A
    Respir Med; 2009 Nov; 103(11):1755-63. PubMed ID: 19375904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases.
    Gueders MM; Foidart JM; Noel A; Cataldo DD
    Eur J Pharmacol; 2006 Mar; 533(1-3):133-44. PubMed ID: 16487964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGFβ-induced matrix production by bronchial fibroblasts in asthma: budesonide and formoterol effects.
    Todorova L; Bjermer L; Westergren-Thorsson G; Miller-Larsson A
    Respir Med; 2011 Sep; 105(9):1296-307. PubMed ID: 21514131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The regulation of fibrosis in airway remodeling in asthma.
    Royce SG; Cheng V; Samuel CS; Tang ML
    Mol Cell Endocrinol; 2012 Apr; 351(2):167-75. PubMed ID: 22266540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Symbicort® versus Pulmicort® on steroid pharmacodynamic markers in asthma patients.
    Essilfie-Quaye S; Ito K; Ito M; Kharitonov SA; Barnes PJ
    Respir Med; 2011 Dec; 105(12):1784-9. PubMed ID: 21903370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Budesonide and formoterol inhibit inflammatory mediator production by bronchial epithelial cells infected with rhinovirus.
    Skevaki CL; Christodoulou I; Spyridaki IS; Tiniakou I; Georgiou V; Xepapadaki P; Kafetzis DA; Papadopoulos NG
    Clin Exp Allergy; 2009 Nov; 39(11):1700-10. PubMed ID: 19549024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.
    Visse R; Nagase H
    Circ Res; 2003 May; 92(8):827-39. PubMed ID: 12730128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Function of the respiratory airways following inhalation of bronchodilator agents in patients with asthma].
    Zapletal A; Samánek M; Paul T; Rakowská S; Copová M; Suková B
    Cas Lek Cesk; 1975 May; 114(21):644-50. PubMed ID: 1131849
    [No Abstract]   [Full Text] [Related]  

  • 10. [Matrix metalloproteinases and their tissue inhibitors].
    Trojanek J
    Postepy Biochem; 2012; 58(3):353-62. PubMed ID: 23373420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperative inhibitory effects of budesonide and formoterol on eosinophil superoxide production stimulated by bronchial epithelial cell conditioned medium.
    Persdotter S; Lindahl M; Malm-Erjefalt M; von Wachenfeldt K; Korn SH; Stevens T; Miller-Larsson A
    Int Arch Allergy Immunol; 2007; 143(3):201-10. PubMed ID: 17290146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of formoterol: an innovative bronchodilator.
    Anderson GP
    Agents Actions Suppl; 1991; 34():97-115. PubMed ID: 1686531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal expression of matrix metalloproteinases and their tissue inhibitors in ulcerative colitis patients.
    Kusugami K; Nobata K; Tsuzuki T; Ando T; Ina K
    J Gastroenterol; 2003; 38(4):412-3. PubMed ID: 12743787
    [No Abstract]   [Full Text] [Related]  

  • 14. Detection of activated, TIMP-free MMPs.
    Zucker S; Cao J
    Chem Biol; 2006 Apr; 13(4):347-9. PubMed ID: 16632246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Metalloproteinases and their inhibitors: the importance of extracellular matrix degradation in malignancy].
    Sela B
    Harefuah; 2000 Dec; 139(11-12):446-51. PubMed ID: 11341192
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of matrix metalloproteinases in melanoma cell invasion.
    Hofmann UB; Houben R; Bröcker EB; Becker JC
    Biochimie; 2005; 87(3-4):307-14. PubMed ID: 15781317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Budesonide turbuhaler for asthma.
    Med Lett Drugs Ther; 1998 Jan; 40(1018):15-6. PubMed ID: 9457158
    [No Abstract]   [Full Text] [Related]  

  • 18. [Matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathogenesis of rheumatoid arthritis].
    Fiedorczyk M; Klimiuk PA; Sierakowski S; Kita K
    Pol Merkur Lekarski; 2006 Feb; 20(116):228-31. PubMed ID: 16708647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinases at a glance.
    Lee MH; Murphy G
    J Cell Sci; 2004 Aug; 117(Pt 18):4015-6. PubMed ID: 15316076
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-inflammatory activity of beta2-agonists in primary lung epithelial cells is independent of glucocorticoid receptor.
    Lovén J; Svitacheva N; Jerre A; Miller-Larsson A; Korn SH
    Eur Respir J; 2007 Nov; 30(5):848-56. PubMed ID: 17596271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.